Pharmacovigilance deep dive: risk minimisation measures
European Pharmaceutical Review
SEPTEMBER 2, 2022
RMMs aim to optimise the safe and effective use of medical products in clinical practice by improving their risk-benefit balance. As does the US Food and Drug Administration (FDA): REMS Assessment: Planning and Reporting Guidance for Industry Draft Guidance. About the author. References. Risk management plan [Internet].
73 
Let's personalize your content